Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pharmaxis raises AUS$16.5M

Pharmaxis (ASX:PXS) raised AUS$16.5 million ($12.4 million) in a

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE